These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17052822)

  • 21. Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 May; 33(ACS-3):1-23. PubMed ID: 17520774
    [No Abstract]   [Full Text] [Related]  

  • 22. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand.
    Lennon D; Jackson C; Wong S; Horsfall M; Stewart J; Reid S
    Clin Infect Dis; 2009 Aug; 49(4):597-605. PubMed ID: 19622040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningococcal vaccine in travelers.
    Wilder-Smith A
    Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
    Trotter CL; Ramsay ME
    FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
    Vogel G
    Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical trials of the new Norwegian vaccine against diseases caused by Meningococcus B].
    Bjune G; Nøkleby H; Hareide B
    Tidsskr Nor Laegeforen; 1990 Feb; 110(5):614-7. PubMed ID: 2408194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conquering the meningococcus.
    Stephens DS
    FEMS Microbiol Rev; 2007 Jan; 31(1):3-14. PubMed ID: 17233633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges and progress in the development of a serogroup B meningococcal vaccine.
    Lewis S; Sadarangani M; Hoe JC; Pollard AJ
    Expert Rev Vaccines; 2009 Jun; 8(6):729-45. PubMed ID: 19485754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial meningitis. Appeal to thwart deadly outbreak.
    Vogel G
    Science; 2002 Oct; 298(5592):339. PubMed ID: 12376673
    [No Abstract]   [Full Text] [Related]  

  • 32. Universal childhood immunisation with pneumococcal vaccine and meningococcal serogroup C vaccine introduced in Germany.
    Wiese-Posselt M; Hellenbrand W; Siedler A; Mayer C
    Euro Surveill; 2006 Sep; 11(9):E060907.4. PubMed ID: 17075143
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quadrivalent meningococcal conjugate vaccine].
    Landry P
    Rev Med Suisse; 2011 May; 7(294):1006-8, 1010. PubMed ID: 21692314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemic meningitis control in countries of the African meningitis belt, 2016.
    Wkly Epidemiol Rec; 2017 Mar; 92(13):145-54. PubMed ID: 28361528
    [No Abstract]   [Full Text] [Related]  

  • 35. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of meningitis outbreaks in the African meningitis belt.
    Obaro SK; Habib AG
    Lancet Infect Dis; 2016 Apr; 16(4):400-2. PubMed ID: 27036337
    [No Abstract]   [Full Text] [Related]  

  • 37. Outbreak of invasive meningococcal disease in Goleniow County, northwest Poland, March 2009.
    Skoczyńska A; Wasko I; Kuch A; Gołebiewska A; Foryś M; Hryniewicz W
    Euro Surveill; 2010 Aug; 15(34):. PubMed ID: 20807486
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).
    Frasch CE; Preziosi MP; LaForce FM
    Hum Vaccin Immunother; 2012 Jun; 8(6):715-24. PubMed ID: 22495119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious disease: Conjugate vaccine is effective against serogroup A meningococcal meningitis.
    Bible E
    Nat Rev Neurol; 2013 Nov; 9(11):602-3. PubMed ID: 24126626
    [No Abstract]   [Full Text] [Related]  

  • 40. Meningococcal conjugate vaccine updates.
    Weber AK; Hayney MS
    J Am Pharm Assoc (2003); 2012; 52(6):855-8. PubMed ID: 23229973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.